Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenrong Wan is an approved traditional Chinese medicine (TCM) product developed and manufactured by Liaoning Jindan Pharmaceutical. Formulated as a pill, its primary active components are derived from Ginseng (*Panax ginseng*) and Deer Antler (*Cervus elaphus*), which are traditionally used in TCM to tonify Qi and blood, strengthen the kidneys, and replenish Yang essence. It is indicated for conditions associated with deficiency of Qi and blood, such as physical weakness, fatigue, soreness in the lower back and knees, and recovery from chronic illness. As a multi-herb TCM formulation, it is registered as a marketed pharmaceutical product in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenrong wan.